Clinical Trial: Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT06376916) titled 'Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR' on April 15.

Brief Summary: The purpose of this prospective, randomized, double-blinded study is to further evaluate the safety and efficacy of varying doses of intravenous magnesium in the treatment of AFF RVR.

Study Type: Interventional

Condition: * Tachycardia Atrial

* Atrial Fibrillation

* Atrial Flutter With Rapid Ventricular Response

Intervention: * Drug: Magnesium Sulfate 2 G

Magnesium Sulfate 2g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR)

Other Name: Magnesium Sulfate 2 gram/5...